RCS - Brit Utd ProvAscBUPA - Bupa announces appointment of new NEDs

AegonAnnouncement

25/01/2024 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240125:nRSY7956Aa&default-theme=true

RNS Number : 7956A  British Utd Provident Assoc (BUPA)  25 January 2024

Bupa appoints Simon Blair and Clare Bousfield as Non-Executive Directors

 

25 January 2024

 

Bupa today announces the appointments of Simon Blair and Clare Bousfield as
Non-Executive Directors with immediate effect.   Both Simon and Clare will
be joining the Audit and Risk Committees and Simon will also join the
Remuneration Committee.

 

Simon's career has been spent in the health care and financial services
industries. This included ten years at Commonwealth Bank of Australia (CBA) in
a number of senior roles including Group Executive, International Financial
Services and Managing Director and CEO of Sovereign Assurance Company Limited.
Before joining CBA, Simon was Chief Operating Officer of Medibank Private in
Australia and had been CEO of Australia's largest hospital group. Simon has
also previously held executive roles with both the World Bank and the IFC
based in Washington DC. Simon previously served on the Bupa Board between 2016
and 2019 and his other previous board appointments include Bank of Hangzhou
Co. Limited and BoCommlife Insurance Company Limited, both in China. Simon
currently serves on the board of ASB Bank in New Zealand and is chair of the
board of Bupa's subsidiary in Chile, Bupa Chile S.A.

 

Clare brings extensive UK financial services experience from her roles at
M&G Plc, where she served as both Group CFO and latterly CEO, Retail &
Savings.  Prior to M&G's demerger from Prudential, Clare served as CEO,
Insurance for Prudential UK & Europe. Prior to her time at Prudential,
Clare held various senior roles at Aegon and Swiss Re Group, having started
her career at PwC.  Clare serves as a non-executive director and chair of the
audit & risk committee of IVC Evidensia, the largest veterinary care
provider across the UK and Europe, and as a member of the board of the
Association of British Insurers.  She also has non-executive experience from
her time as a non-executive director and chair of the audit committee of RSA
Insurance Group plc.

 

Roger Davis, Chairman of Bupa said: "We are delighted to welcome Clare, and
welcome back Simon, to the Bupa Board.  Their appointments will further
strengthen the financial services experience on the Board in our key markets
at an important time in Bupa's strategic development, and I look forward to
working with them both."

 

 

The British United Provident Association Limited (BUPA 1025Z LN)

 ENDS 

About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives and
making a better world. Bupa is an international healthcare company serving
over 43 million customers worldwide. With no shareholders, Bupa reinvests
profits into providing more and better healthcare for the benefit of current
and future customers. Bupa directly employs around 82,000 people, principally
in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR,
Türkiye, Brazil, Mexico, the US, Middle East and Ireland. Bupa also has
associate businesses in Saudi Arabia and India.

For more information, visit bupa.com
(https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.bupa.com%2F&data=05%7C02%7CTracey.Crosier%40BUPA.com%7C6ff7bd8e92c9458aa9ae08dc1759fde1%7C02af5f5edd71405680903e7b436a65db%7C0%7C0%7C638410922490363515%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=vabIxk3%2BlJJgYop9249kIMxF9yc14flnTMW%2BBOHcyyg%3D&reserved=0)

Media contacts

Duncan West    duncan.west@bupa.com (mailto:duncan.west@bupa.com)

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPPURWGUPCGGC